1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Resectable Soft Tissue Sarcoma: new trials by email Literature Review of Resectable Soft Tissue Sarcoma trials Research Report on Resectable Soft Tissue Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall Biospecimen Collection, Computed Tomography, Doxorubicin - Resectable Liposarcoma, Resectable Soft Tissue Sarcoma | Phase 3 | Not yet recruiting | Ohio State University Comprehensive Cancer Center | 228 | 2026-12-01 | 2026-09-16 |
Doxorubicin (1) · Ifosfamide (1) · Magnetic Resonance Spectroscopy (1) · Radiotherapy, Intensity-Modulated (1) · Specimen Handling (1) · Surgical Procedures, Operative (1) · pembrolizumab (1)
Ohio State University Comprehensive Cancer Center (1)
United States (1)
David A Liebner (1)